Combination immunotherapy with interleukin‐2 surface‐modified tumor cell vaccine and programmed death receptor‐1 blockade against renal cell carcinoma

por Zhang, Xinji, Shi, Xiaojun, Li, Jinlong, Hu, Zhiming, Gao, Jimin, Wu, Shihao, Long, Zhaolin
Publicado 2018

LncARSR sponges miR-129-5p to promote proliferation and metastasis of bladder cancer cells through increasing SOX4 expression

por Liao, Chunxian, Long, Zhaolin, Zhang, Xinji, Cheng, Jianli, Qi, Fuming, Wu, Shihao, Huang, Tao
Publicado 2020

PD-1 Blockade Overcomes Adaptive Immune Resistance in Treatment with Anchored-GM-CSF Bladder Cancer Cells Vaccine

por Zhang, Xinji, Shi, Xiaojun, Li, Jinlong, Mo, Lijun, Hu, Zhiming, Gao, Jimin, Wu, Shihao, Long, Zhaolin
Publicado 2018

Sequential administration of anti-PD-1 and anti-Tim-3 combined with an SA-GM-CSF-anchored vaccine overcomes adaptive immune resistance to reject established bladder cancer

por Zhang, Xinji, Liu, Guang, Shi, Xianghua, Shi, Xiaojun, Li, Jinlong, Mo, Lijun, Gao, Jimin, Long, Zhaolin, Tan, Wanlong
Publicado 2021

Increased Tim-3 expression on TILs during treatment with the Anchored GM-CSF vaccine and anti-PD-1 antibodies is inversely correlated with response in prostate cancer

por Zhang, Xinji, Chen, Haixiong, Li, Guanfeng, Zhou, Xiangyun, Shi, Yuqiang, Zou, Feng, Chen, Yuanxiang, Gao, Jimin, Yang, Shaomin, Wu, Shihao, Long, Zhaolin
Publicado 2020

Crystal structure and catalytic mechanism of the MbnBC holoenzyme required for methanobactin biosynthesis

por Dou, Chao, Long, Zhaolin, Li, Shoujie, Zhou, Dan, Jin, Ying, Zhang, Li, Zhang, Xuan, Zheng, Yanhui, Li, Lin, Zhu, Xiaofeng, Liu, Zheng, He, Siyu, Yan, Weizhu, Yang, Lulu, Xiong, Jie, Fu, Xianghui, Qi, Shiqian, Ren, Haiyan, Chen, She, Dai, Lunzhi, Wang, Binju, Cheng, Wei
Publicado 2022